Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors

作者：Y. Zhu, Shaofeng Jiang, Y. Shi, Shixuan Wang, Fenghong Yuan, Fangjian Zhou, Kui Jiang, Xian Zhang, Lasika Seneviratne, Guan Yu Yu, Mingjun Zhang, Tao Liu, Xin Li, Xi Chen, Xian Wang, Xiaofeng Zhang, Yunpeng Liu, Yuanyuan Ge, Ming Chen, Gideon M. Blumenthal, Omobolaji O. Akala, Y Li, Xiuyang Li, Joy Yang Ge, Dingwei Ye · 发表于：Annals of Oncology · 年份：2025 · DOI：10.1016/j.annonc.2025.11.013 · 被引用次数：5 · 研究领域：Bladder and Urothelial Cancer Treatments、Cancer Immunotherapy and Biomarkers、Renal cell carcinoma treatment